Talis Biomedical Corporation

TLIS62

Penny Stock

$1.75arrow_drop_down1.68%-$0.03

Penny Stock

TLIS62

$1.75

arrow_drop_down1.68%-$0.03

Penny Stock

Performance History

Key Stats
Open	$1.69
Prev. Close	$1.78
EPS	-28.02
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$3.28M
PE Ratio	-

	LOW	HIGH
Day Range	1.69	1.75
52 Week Range	1.37	9.60

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-28.02

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Talis Biomedical Corporation (TLIS)

Talis Biomedical Corporation (TLIS) is a cutting-edge biotech company that specializes in developing innovative diagnostic tools and technologies. With a strong emphasis on molecular diagnostics, Talis Biomedical Corporation is revolutionizing the field of healthcare by providing accurate and rapid diagnostic solutions. TLIS's stock price history has witnessed significant growth over the years, reflecting the market's recognition of their groundbreaking advancements.

TLIS's quote reflects the latest trading price of Talis Biomedical Corporation's stock. Investors can access this information to make informed decisions about their investments. Additionally, staying updated with TLIS's stock news is vital for investors to keep track of any significant developments or announcements that may impact the company's performance in the market.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Robert Kelley MBA
Headquarters: Redwood City
Employees: 102
Exchange: NASDAQ

add Talis Biomedical Corporation to watchlist

Keep an eye on Talis Biomedical Corporation

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Talis Biomedical Corporation's (TLIS) price per share?

The current price per share for Talis Biomedical Corporation (TLIS) is $1.75. The stock has seen a price change of -$0.03 recently, indicating a -1.69% change. This reflects the stock's recent market performance and investor sentiment.

help

Is Talis Biomedical Corporation (TLIS) a growth stock?

Talis Biomedical Corporation (TLIS) has shown an average price growth of -4.94% over the past three years. It has received a score of 1 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Talis Biomedical Corporation as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is the 52-week high and low for Talis Biomedical Corporation (TLIS)?

For Talis Biomedical Corporation (TLIS), the 52-week high is $9.6, which is 448.57% from the current price. The 52-week low is $1.37, the current price is 27.74% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

What is Talis Biomedical Corporation (TLIS) stock price performance year to date (YTD)?

As of the latest data, Talis Biomedical Corporation (TLIS) has a year-to-date price change of -78.23%. Over the past month, the stock has experienced a price change of 3.6%. Over the last three months, the change has been -56.36%. Over the past six months, the figure is -79.93%.

help

Is Talis Biomedical Corporation (TLIS) a profitable company?

Talis Biomedical Corporation (TLIS) has a net income of -$62.01M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -11.36K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$65.77M. Furthermore, the EBITDA is -$45.58M.

help

What is the market capitalization of Talis Biomedical Corporation (TLIS)?

Talis Biomedical Corporation (TLIS) has a market capitalization of $3.21M. The average daily trading volume is 7.05K, indicating the stock's liquidity and investor engagement.